SNP Shot: Genomic Insights

Unlock the secrets of your DNA. Secure. Detailed. Informative.

Sialidosis

Sialidosis is a serious inherited condition impacting multiple organ systems, including the nervous system. It is classified into two main types based on the age of symptom onset and the severity of the condition.

Sialidosis type I, also known as cherry-red spot myoclonus syndrome, is the milder form. Symptoms usually begin in adolescence or early adulthood (teens to twenties). Initial symptoms include difficulty walking (gait disturbance) and/or vision loss (reduced visual acuity). Affected individuals also experience muscle twitching (myoclonus), coordination problems (ataxia), tremors in the legs, and seizures. The myoclonus progressively worsens, making it difficult to sit, stand, or walk, often leading to the need for a wheelchair. Vision problems worsen over time, potentially including color vision deficits or night blindness. A characteristic eye abnormality called a cherry-red spot, detectable during an eye exam, is a hallmark of this condition. Importantly, sialidosis type I does not affect intelligence or lifespan.

Sialidosis type II, the more severe form, is further subdivided into congenital, infantile, and juvenile forms. Congenital sialidosis type II features can manifest before birth. This form is associated with fluid buildup in the abdomen (ascites) or widespread swelling due to fluid accumulation (hydrops fetalis). Affected infants may also have an enlarged liver and spleen (hepatosplenomegaly), abnormal bone development (dysostosis multiplex), and distinctive facial features described as "coarse." Due to these severe health issues, infants with congenital sialidosis type II are often stillborn or die shortly after birth.

Infantile sialidosis type II shares some characteristics with the congenital form, but its symptoms are slightly less severe and emerge within the first year of life. Common features include hepatosplenomegaly, dysostosis multiplex, "coarse" facial features, short stature, and intellectual disability. As children with infantile sialidosis type II age, they may develop myoclonus and cherry-red spots. Additional symptoms may include hearing loss, gum overgrowth (gingival hyperplasia), and widely spaced teeth. Individuals with the infantile form may survive into childhood or adolescence.

The juvenile form of sialidosis type II presents with the mildest symptoms. These features typically appear in late childhood and may include subtle "coarse" facial features, minor bone abnormalities, cherry-red spots, myoclonus, intellectual disability, and dark red spots on the skin (angiokeratomas). Life expectancy for individuals with juvenile sialidosis type II varies depending on the severity of the symptoms.

Inheritance:

Sialidosis is inherited in an autosomal recessive manner. This means that both copies of the responsible gene in each cell must have mutations for the condition to develop. Parents of an individual with an autosomal recessive disorder each carry one copy of the mutated gene, but usually do not exhibit any signs or symptoms of the condition themselves.

Related Conditions:

Cherry red spot myoclonus syndrome Mucolipidosis I Mucolipidosis type I Myoclonus cherry red spot syndrome

Category:

Single

Associated RSIDs:

NCBI dbSNP

rs137854547
rs281864976
rs137852896
rs281865025
rs281865031
rs1310267862
rs765577483
rs757574720
rs1394425220
rs896210352
rs281864999
rs769812697
rs104893972
rs104893985
rs138390866
rs281865007
rs121908374
rs763678034
rs281865010
rs281864955
rs281864998
rs34788341
rs281864963
rs1245543262
rs1056159821
rs1257678960
rs1298654156
rs1952988471
rs137852900
rs200646278
rs281865029
rs104893977
rs753382639
rs34946266
rs281864982
rs34940801
rs397507448
rs1043530261
rs193302847
rs886041533
rs786200859
rs1429181351
rs1391863896
rs137852899
rs779474781
rs1441014377
rs1869312922
rs1555269488
rs757685298
rs137854544
rs281865026
rs281865036
rs137852898
rs281864979
rs945372017
rs281865018
rs752247255
rs281865017
rs398124400
rs770176191
rs281864989
rs797044823
rs281864995
rs397507447
rs1871323854
rs864309513
rs769765227
rs2022547761
rs1408113895
rs1953155498
rs281864968
rs193302855
rs1486980139
rs397507562
rs1336176104
rs281865024
rs1568398702
rs756959430
rs137852885
rs193302849
rs747789493
rs768711214
rs281865023
rs1349755445
rs36007394
rs773452586
rs281865028
rs281864969
rs1310955639
rs1953327287
rs137854545
rs193302848
rs281864983
rs35333334
rs281864959
rs751298168
rs137852897
rs137854548
rs281864991
rs281865009
rs281865012
rs746607723
rs104886461
rs281865016
rs776845391
rs121908372
rs281864970
rs794727302
rs1953165554
rs281864988
rs281865008
rs281865038
rs1368027694
rs281865003
rs142065232
rs121908373
rs1278279828
rs193302854
rs281864962
rs104893984
rs781689303
rs1953064841
rs281865006
rs281864954
rs774506925
rs534846786
rs377553632
rs1301743166
rs1060499680
rs753596034
rs797044822
rs193922915
rs78347057
rs281864980
rs754405067
rs751458617
rs104893980
rs281864985
rs28940583
rs104893979
rs137854540
rs281864973
rs104893983
rs281864964
rs104893978
rs1594214799
rs281865020
rs35878526
rs1479370932
rs34002892
rs1201536920
rs193302858
rs137852884
rs193302850
rs398123392
rs1337995343

Source:

View on MedlinePlus

Back to Topics List